Taken together, these findings suggest that therapeutic approaches targeting the miR-25/SESN3 axis would be most beneficial as a preventive measure in high-risk patients or as an immediate intervention following myocardial infarction. This evidence concerns the gene SESN3 and myocardial infarction.